Related Experiment Video
Updated: Feb 24, 2026

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians
Published on: March 14, 2014
Drawbacks of the use of cotrimoxazole in foreign-body infections
Cristina El Haj1, Alba Ribera1, Nuria Lloberas2
1Laboratory of Experimental Infection, Infectious Diseases Service, IDIBELL-Hospital Universitari Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.
Introduction:
The anti-staphylococcal efficacy of cotrimoxazole in the setting of difficult-to-treat infections seems to be compromised by large amounts of pus and devitalized tissue, and, therefore, high levels of thymidine. Our objective was to evaluate the activity of cotrimoxazole against a staphylococcal foreign-body infection experimental model, which also yields significant quantities of thymidine.
Material And Methods:
We used a rat tissue-cage model of infection (with high inherent thymidine levels) caused by a strain of methicillin-susceptible Staphylococcus aureus (MSSA; ATCC 29213). MIC values were determined (microdilution method) and compared in the presence or absence of tissue-cage fluid samples.
Results:
The inefficacy of cotrimoxazole was found to be similar to that of the control group. The MIC of cotrimoxazole was 4-8 fold higher in the presence of rat tissue-cage fluid.
Conclusions:
The inefficacy of cotrimoxazole in our foreign-body infection model by MSSA, and the probable negative impact of the presence of thymidine on its efficacy, challenge the use of this drug in acute phases of foreign-body infections. It should be reserved as an alternative treatment when the infection is more controlled.
Insights
Cotrimoxazole shows reduced effectiveness against Staphylococcus aureus infections in foreign-body models due to high thymidine levels. This suggests reserving cotrimoxazole for later stages of infection treatment.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Background:
- Cotrimoxazole efficacy is potentially reduced in difficult infections with high thymidine levels.
- Foreign-body infections often involve significant pus and devitalized tissue, leading to high thymidine concentrations.
Purpose of the Study:
- To evaluate cotrimoxazole activity against Staphylococcus aureus in an experimental foreign-body infection model.
- To assess the impact of high thymidine levels on cotrimoxazole's anti-staphylococcal efficacy.
Main Methods:
- Utilized a rat tissue-cage model of infection with methicillin-susceptible Staphylococcus aureus (MSSA).
- Determined Minimum Inhibitory Concentration (MIC) values using a microdilution method.
- Compared MICs in the presence and absence of tissue-cage fluid containing high thymidine levels.
Main Results:
- Cotrimoxazole demonstrated inefficacy in the foreign-body infection model, similar to the control group.
- The MIC of cotrimoxazole was 4-8 fold higher when tested in the presence of rat tissue-cage fluid.
Conclusions:
- Cotrimoxazole's inefficacy in this MSSA foreign-body infection model highlights the negative impact of thymidine.
- The findings challenge the use of cotrimoxazole during the acute phase of foreign-body infections.
- Cotrimoxazole should be considered an alternative treatment option once the infection is better controlled.
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Urine Studies II: Urine Culture and Sensitivity Test
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

